Review





Similar Products

plasmid encoding the hit receptor with flanking homology arm sequences  (Twist Bioscience)
90
Twist Bioscience plasmid encoding the hit receptor with flanking homology arm sequences
Plasmid Encoding The Hit Receptor With Flanking Homology Arm Sequences, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hits+encoder/pm40097658-349-2-13?v=Twist+Bioscience
Average 90 stars, based on 1 article reviews
plasmid encoding the hit receptor with flanking homology arm sequences - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
2.53 µg plasmid dna encoding a membrane protein hit  (Charles River Laboratories)
90
Charles River Laboratories 2.53 µg plasmid dna encoding a membrane protein hit
a Schematic of AAV cell microarray screen. <t>DNA</t> oligos that encode individual membrane proteins are chemically coupled to slides in a known pattern, reverse transfecting the cells that grow on them and thereby creating spots of cells overexpressing a particular, known protein. Each protein is expressed in duplicate at two different locations on the slide. When AAVs are applied to the slides, enhanced binding can be detected from duplicate cell spots overexpressing cognate AAV receptors. b Known AAV capsid receptor interactions, such as AAVR and LY6A with AAV-PHP.eB, were used to optimize conditions for streptavidin-based detection of biotinylated capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV positive control. Uncropped blots in source data. c AAVR and LY6A interaction with AAV9.CAP-B22 were used to optimize conditions for anti-AAV9 antibody direct detection of unmodified capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV control. Uncropped blots in source data. d Pooled AAV capsid screening conditions were optimized by varying the concentrations of individual capsids within the pool to maximize signal to noise after direct detection with anti-AAV9 antibody, with two sets of replicate spots. v.g.: viral genomes. Uncropped blots in source data. e Pooled screening identified preliminary hits which were deconvoluted by individual-capsid screens, identifying previously-unreported potential capsid-binding proteins by direct detection with anti-AAV9 antibody. Transfection control condition detected fluorescent protein <t>reverse</t> <t>transfected</t> along with each receptor. None condition was treated only with anti-AAV9 antibody. Proteins in cyan were identified in all individual AAV screens, and likely represent interactions outside the engineered regions of AAV9. Proteins in magenta specifically bind to at least one engineered capsid. Uncropped blots in source data. Panel a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
2.53 µg Plasmid Dna Encoding A Membrane Protein Hit, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hits+encoder/pmc11381518-280-10-19?v=Charles+River+Laboratories
Average 90 stars, based on 1 article reviews
2.53 µg plasmid dna encoding a membrane protein hit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
peptides encoding hit sequences  (GenScript corporation)
90
GenScript corporation peptides encoding hit sequences
a Schematic of AAV cell microarray screen. <t>DNA</t> oligos that encode individual membrane proteins are chemically coupled to slides in a known pattern, reverse transfecting the cells that grow on them and thereby creating spots of cells overexpressing a particular, known protein. Each protein is expressed in duplicate at two different locations on the slide. When AAVs are applied to the slides, enhanced binding can be detected from duplicate cell spots overexpressing cognate AAV receptors. b Known AAV capsid receptor interactions, such as AAVR and LY6A with AAV-PHP.eB, were used to optimize conditions for streptavidin-based detection of biotinylated capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV positive control. Uncropped blots in source data. c AAVR and LY6A interaction with AAV9.CAP-B22 were used to optimize conditions for anti-AAV9 antibody direct detection of unmodified capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV control. Uncropped blots in source data. d Pooled AAV capsid screening conditions were optimized by varying the concentrations of individual capsids within the pool to maximize signal to noise after direct detection with anti-AAV9 antibody, with two sets of replicate spots. v.g.: viral genomes. Uncropped blots in source data. e Pooled screening identified preliminary hits which were deconvoluted by individual-capsid screens, identifying previously-unreported potential capsid-binding proteins by direct detection with anti-AAV9 antibody. Transfection control condition detected fluorescent protein <t>reverse</t> <t>transfected</t> along with each receptor. None condition was treated only with anti-AAV9 antibody. Proteins in cyan were identified in all individual AAV screens, and likely represent interactions outside the engineered regions of AAV9. Proteins in magenta specifically bind to at least one engineered capsid. Uncropped blots in source data. Panel a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Peptides Encoding Hit Sequences, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hits+encoder/pm37988460-306-0-7?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
peptides encoding hit sequences - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
dna-encoded library hit  (Glaxo Smith)
90
Glaxo Smith dna-encoded library hit
a Schematic of AAV cell microarray screen. <t>DNA</t> oligos that encode individual membrane proteins are chemically coupled to slides in a known pattern, reverse transfecting the cells that grow on them and thereby creating spots of cells overexpressing a particular, known protein. Each protein is expressed in duplicate at two different locations on the slide. When AAVs are applied to the slides, enhanced binding can be detected from duplicate cell spots overexpressing cognate AAV receptors. b Known AAV capsid receptor interactions, such as AAVR and LY6A with AAV-PHP.eB, were used to optimize conditions for streptavidin-based detection of biotinylated capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV positive control. Uncropped blots in source data. c AAVR and LY6A interaction with AAV9.CAP-B22 were used to optimize conditions for anti-AAV9 antibody direct detection of unmodified capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV control. Uncropped blots in source data. d Pooled AAV capsid screening conditions were optimized by varying the concentrations of individual capsids within the pool to maximize signal to noise after direct detection with anti-AAV9 antibody, with two sets of replicate spots. v.g.: viral genomes. Uncropped blots in source data. e Pooled screening identified preliminary hits which were deconvoluted by individual-capsid screens, identifying previously-unreported potential capsid-binding proteins by direct detection with anti-AAV9 antibody. Transfection control condition detected fluorescent protein <t>reverse</t> <t>transfected</t> along with each receptor. None condition was treated only with anti-AAV9 antibody. Proteins in cyan were identified in all individual AAV screens, and likely represent interactions outside the engineered regions of AAV9. Proteins in magenta specifically bind to at least one engineered capsid. Uncropped blots in source data. Panel a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Dna Encoded Library Hit, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hits+encoder/pm34591474-131-3-1?v=Glaxo+Smith
Average 90 stars, based on 1 article reviews
dna-encoded library hit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
head impact telemetry system (hits) encoders  (Simbex Inc)
90
Simbex Inc head impact telemetry system (hits) encoders
a Schematic of AAV cell microarray screen. <t>DNA</t> oligos that encode individual membrane proteins are chemically coupled to slides in a known pattern, reverse transfecting the cells that grow on them and thereby creating spots of cells overexpressing a particular, known protein. Each protein is expressed in duplicate at two different locations on the slide. When AAVs are applied to the slides, enhanced binding can be detected from duplicate cell spots overexpressing cognate AAV receptors. b Known AAV capsid receptor interactions, such as AAVR and LY6A with AAV-PHP.eB, were used to optimize conditions for streptavidin-based detection of biotinylated capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV positive control. Uncropped blots in source data. c AAVR and LY6A interaction with AAV9.CAP-B22 were used to optimize conditions for anti-AAV9 antibody direct detection of unmodified capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV control. Uncropped blots in source data. d Pooled AAV capsid screening conditions were optimized by varying the concentrations of individual capsids within the pool to maximize signal to noise after direct detection with anti-AAV9 antibody, with two sets of replicate spots. v.g.: viral genomes. Uncropped blots in source data. e Pooled screening identified preliminary hits which were deconvoluted by individual-capsid screens, identifying previously-unreported potential capsid-binding proteins by direct detection with anti-AAV9 antibody. Transfection control condition detected fluorescent protein <t>reverse</t> <t>transfected</t> along with each receptor. None condition was treated only with anti-AAV9 antibody. Proteins in cyan were identified in all individual AAV screens, and likely represent interactions outside the engineered regions of AAV9. Proteins in magenta specifically bind to at least one engineered capsid. Uncropped blots in source data. Panel a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Head Impact Telemetry System (Hits) Encoders, supplied by Simbex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hits+encoder/pmc06685720-43-18-24?v=Simbex+Inc
Average 90 stars, based on 1 article reviews
head impact telemetry system (hits) encoders - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
riddell head impact telemetry system (hits) encoder  (Simbex Inc)
90
Simbex Inc riddell head impact telemetry system (hits) encoder
a Schematic of AAV cell microarray screen. <t>DNA</t> oligos that encode individual membrane proteins are chemically coupled to slides in a known pattern, reverse transfecting the cells that grow on them and thereby creating spots of cells overexpressing a particular, known protein. Each protein is expressed in duplicate at two different locations on the slide. When AAVs are applied to the slides, enhanced binding can be detected from duplicate cell spots overexpressing cognate AAV receptors. b Known AAV capsid receptor interactions, such as AAVR and LY6A with AAV-PHP.eB, were used to optimize conditions for streptavidin-based detection of biotinylated capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV positive control. Uncropped blots in source data. c AAVR and LY6A interaction with AAV9.CAP-B22 were used to optimize conditions for anti-AAV9 antibody direct detection of unmodified capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV control. Uncropped blots in source data. d Pooled AAV capsid screening conditions were optimized by varying the concentrations of individual capsids within the pool to maximize signal to noise after direct detection with anti-AAV9 antibody, with two sets of replicate spots. v.g.: viral genomes. Uncropped blots in source data. e Pooled screening identified preliminary hits which were deconvoluted by individual-capsid screens, identifying previously-unreported potential capsid-binding proteins by direct detection with anti-AAV9 antibody. Transfection control condition detected fluorescent protein <t>reverse</t> <t>transfected</t> along with each receptor. None condition was treated only with anti-AAV9 antibody. Proteins in cyan were identified in all individual AAV screens, and likely represent interactions outside the engineered regions of AAV9. Proteins in magenta specifically bind to at least one engineered capsid. Uncropped blots in source data. Panel a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Riddell Head Impact Telemetry System (Hits) Encoder, supplied by Simbex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hits+encoder/pm29966462-32-14-13?v=Simbex+Inc
Average 90 stars, based on 1 article reviews
riddell head impact telemetry system (hits) encoder - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
plasmids encoding viral packaging proteins vsvg and hit-60  (Promega)
90
Promega plasmids encoding viral packaging proteins vsvg and hit-60
a Schematic of AAV cell microarray screen. <t>DNA</t> oligos that encode individual membrane proteins are chemically coupled to slides in a known pattern, reverse transfecting the cells that grow on them and thereby creating spots of cells overexpressing a particular, known protein. Each protein is expressed in duplicate at two different locations on the slide. When AAVs are applied to the slides, enhanced binding can be detected from duplicate cell spots overexpressing cognate AAV receptors. b Known AAV capsid receptor interactions, such as AAVR and LY6A with AAV-PHP.eB, were used to optimize conditions for streptavidin-based detection of biotinylated capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV positive control. Uncropped blots in source data. c AAVR and LY6A interaction with AAV9.CAP-B22 were used to optimize conditions for anti-AAV9 antibody direct detection of unmodified capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV control. Uncropped blots in source data. d Pooled AAV capsid screening conditions were optimized by varying the concentrations of individual capsids within the pool to maximize signal to noise after direct detection with anti-AAV9 antibody, with two sets of replicate spots. v.g.: viral genomes. Uncropped blots in source data. e Pooled screening identified preliminary hits which were deconvoluted by individual-capsid screens, identifying previously-unreported potential capsid-binding proteins by direct detection with anti-AAV9 antibody. Transfection control condition detected fluorescent protein <t>reverse</t> <t>transfected</t> along with each receptor. None condition was treated only with anti-AAV9 antibody. Proteins in cyan were identified in all individual AAV screens, and likely represent interactions outside the engineered regions of AAV9. Proteins in magenta specifically bind to at least one engineered capsid. Uncropped blots in source data. Panel a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Plasmids Encoding Viral Packaging Proteins Vsvg And Hit 60, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hits+encoder/pmc05410263-185-39-40?v=Promega
Average 90 stars, based on 1 article reviews
plasmids encoding viral packaging proteins vsvg and hit-60 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
plasmid encoding viral packaging proteins hit-60  (Promega)
90
Promega plasmid encoding viral packaging proteins hit-60
a Schematic of AAV cell microarray screen. <t>DNA</t> oligos that encode individual membrane proteins are chemically coupled to slides in a known pattern, reverse transfecting the cells that grow on them and thereby creating spots of cells overexpressing a particular, known protein. Each protein is expressed in duplicate at two different locations on the slide. When AAVs are applied to the slides, enhanced binding can be detected from duplicate cell spots overexpressing cognate AAV receptors. b Known AAV capsid receptor interactions, such as AAVR and LY6A with AAV-PHP.eB, were used to optimize conditions for streptavidin-based detection of biotinylated capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV positive control. Uncropped blots in source data. c AAVR and LY6A interaction with AAV9.CAP-B22 were used to optimize conditions for anti-AAV9 antibody direct detection of unmodified capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV control. Uncropped blots in source data. d Pooled AAV capsid screening conditions were optimized by varying the concentrations of individual capsids within the pool to maximize signal to noise after direct detection with anti-AAV9 antibody, with two sets of replicate spots. v.g.: viral genomes. Uncropped blots in source data. e Pooled screening identified preliminary hits which were deconvoluted by individual-capsid screens, identifying previously-unreported potential capsid-binding proteins by direct detection with anti-AAV9 antibody. Transfection control condition detected fluorescent protein <t>reverse</t> <t>transfected</t> along with each receptor. None condition was treated only with anti-AAV9 antibody. Proteins in cyan were identified in all individual AAV screens, and likely represent interactions outside the engineered regions of AAV9. Proteins in magenta specifically bind to at least one engineered capsid. Uncropped blots in source data. Panel a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Plasmid Encoding Viral Packaging Proteins Hit 60, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hits+encoder/pm25753204-54-13-24?v=Promega
Average 90 stars, based on 1 article reviews
plasmid encoding viral packaging proteins hit-60 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
hits encoder  (Simbex Inc)
90
Simbex Inc hits encoder
a Schematic of AAV cell microarray screen. <t>DNA</t> oligos that encode individual membrane proteins are chemically coupled to slides in a known pattern, reverse transfecting the cells that grow on them and thereby creating spots of cells overexpressing a particular, known protein. Each protein is expressed in duplicate at two different locations on the slide. When AAVs are applied to the slides, enhanced binding can be detected from duplicate cell spots overexpressing cognate AAV receptors. b Known AAV capsid receptor interactions, such as AAVR and LY6A with AAV-PHP.eB, were used to optimize conditions for streptavidin-based detection of biotinylated capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV positive control. Uncropped blots in source data. c AAVR and LY6A interaction with AAV9.CAP-B22 were used to optimize conditions for anti-AAV9 antibody direct detection of unmodified capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV control. Uncropped blots in source data. d Pooled AAV capsid screening conditions were optimized by varying the concentrations of individual capsids within the pool to maximize signal to noise after direct detection with anti-AAV9 antibody, with two sets of replicate spots. v.g.: viral genomes. Uncropped blots in source data. e Pooled screening identified preliminary hits which were deconvoluted by individual-capsid screens, identifying previously-unreported potential capsid-binding proteins by direct detection with anti-AAV9 antibody. Transfection control condition detected fluorescent protein <t>reverse</t> <t>transfected</t> along with each receptor. None condition was treated only with anti-AAV9 antibody. Proteins in cyan were identified in all individual AAV screens, and likely represent interactions outside the engineered regions of AAV9. Proteins in magenta specifically bind to at least one engineered capsid. Uncropped blots in source data. Panel a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.
Hits Encoder, supplied by Simbex Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hits+encoder/pmc04346375-66-27-23?v=Simbex+Inc
Average 90 stars, based on 1 article reviews
hits encoder - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


a Schematic of AAV cell microarray screen. DNA oligos that encode individual membrane proteins are chemically coupled to slides in a known pattern, reverse transfecting the cells that grow on them and thereby creating spots of cells overexpressing a particular, known protein. Each protein is expressed in duplicate at two different locations on the slide. When AAVs are applied to the slides, enhanced binding can be detected from duplicate cell spots overexpressing cognate AAV receptors. b Known AAV capsid receptor interactions, such as AAVR and LY6A with AAV-PHP.eB, were used to optimize conditions for streptavidin-based detection of biotinylated capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV positive control. Uncropped blots in source data. c AAVR and LY6A interaction with AAV9.CAP-B22 were used to optimize conditions for anti-AAV9 antibody direct detection of unmodified capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV control. Uncropped blots in source data. d Pooled AAV capsid screening conditions were optimized by varying the concentrations of individual capsids within the pool to maximize signal to noise after direct detection with anti-AAV9 antibody, with two sets of replicate spots. v.g.: viral genomes. Uncropped blots in source data. e Pooled screening identified preliminary hits which were deconvoluted by individual-capsid screens, identifying previously-unreported potential capsid-binding proteins by direct detection with anti-AAV9 antibody. Transfection control condition detected fluorescent protein reverse transfected along with each receptor. None condition was treated only with anti-AAV9 antibody. Proteins in cyan were identified in all individual AAV screens, and likely represent interactions outside the engineered regions of AAV9. Proteins in magenta specifically bind to at least one engineered capsid. Uncropped blots in source data. Panel a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.

Journal: Nature Communications

Article Title: Human cell surface-AAV interactomes identify LRP6 as blood-brain barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder

doi: 10.1038/s41467-024-52149-0

Figure Lengend Snippet: a Schematic of AAV cell microarray screen. DNA oligos that encode individual membrane proteins are chemically coupled to slides in a known pattern, reverse transfecting the cells that grow on them and thereby creating spots of cells overexpressing a particular, known protein. Each protein is expressed in duplicate at two different locations on the slide. When AAVs are applied to the slides, enhanced binding can be detected from duplicate cell spots overexpressing cognate AAV receptors. b Known AAV capsid receptor interactions, such as AAVR and LY6A with AAV-PHP.eB, were used to optimize conditions for streptavidin-based detection of biotinylated capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV positive control. Uncropped blots in source data. c AAVR and LY6A interaction with AAV9.CAP-B22 were used to optimize conditions for anti-AAV9 antibody direct detection of unmodified capsids with two sets of replicate spots. Anti-TGFBR2 antibody was used as a non-AAV control. Uncropped blots in source data. d Pooled AAV capsid screening conditions were optimized by varying the concentrations of individual capsids within the pool to maximize signal to noise after direct detection with anti-AAV9 antibody, with two sets of replicate spots. v.g.: viral genomes. Uncropped blots in source data. e Pooled screening identified preliminary hits which were deconvoluted by individual-capsid screens, identifying previously-unreported potential capsid-binding proteins by direct detection with anti-AAV9 antibody. Transfection control condition detected fluorescent protein reverse transfected along with each receptor. None condition was treated only with anti-AAV9 antibody. Proteins in cyan were identified in all individual AAV screens, and likely represent interactions outside the engineered regions of AAV9. Proteins in magenta specifically bind to at least one engineered capsid. Uncropped blots in source data. Panel a created with BioRender.com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license.

Article Snippet: At 80% confluency, cells were transiently transfected with 2.53 µg plasmid DNA encoding a membrane protein hit from the Retrogenix cell microarray screen.

Techniques: Microarray, Membrane, Binding Assay, Positive Control, Control, Transfection